PV Bulletin

Increased risk of wear and corrosion identified with certain cobalt chrome modular neck hip replacements

MHRA warns NHS trusts to conduct clinical reviews for patients with specific cobalt-chrome hip replacements due to wear and corrosion risks.

PV Impact Brief

Urgency: HighConfidence: high

What changed

NHS trusts and hospitals are advised to identify patients with specific cobalt-chrome modular neck components and invite them for clinical reviews to discuss potential risks.

Why it matters

This revision is crucial as complications such as tissue reactions from wear can necessitate revision surgeries, affecting patient safety and healthcare outcomes.

Action needed

Healthcare providers must implement a follow-up process for patients with identified cobalt-chrome modular neck components, monitoring for new or unexpected symptoms including pain, stiffness, or instability.

Relevant for
Medical Safety Lead
Processes impacted
Signal Management
Owner

Regulatory Intelligence Lead

Review cadence

Regular updates as new safety data emerges.

Evidence and confidence

Confidence: highSource updated: Aug 26, 2026

Full briefing

Practical implication

Healthcare providers must implement a follow-up process for patients with identified cobalt-chrome modular neck components, monitoring for new or unexpected symptoms including pain, stiffness, or instability.

The Medicines and Healthcare products Regulatory Agency (MHRA) has identified an increased risk of wear and corrosion in cobalt-chrome modular neck hip replacements. As a precaution, NHS trusts are instructed to notify and invite approximately 750 patients with these devices for clinical reviews.

What changed: NHS trusts and hospitals are advised to identify patients with specific cobalt-chrome modular neck components and invite them for clinical reviews to discuss potential risks.

Why it matters: This revision is crucial as complications such as tissue reactions from wear can necessitate revision surgeries, affecting patient safety and healthcare outcomes.

Practical implication: Healthcare providers must implement a follow-up process for patients with identified cobalt-chrome modular neck components, monitoring for new or unexpected symptoms including pain, stiffness, or instability.

View original source

  • Source: MHRA - News and communications
  • Published at source: 2026-08-26T00:00:00.000Z
  • Discovered by monitor: 2026-08-26T23:35:59.462Z

Published from the regulator source ingestion pipeline after PV impact triage.

Related updates for your role

publicFDA · USA · Updated Sep 4, 2026

FDA Grants Accelerated Approval to Etcamah for Advanced Breast Cancer

Urgency: High

Regulatory teams must prepare for updating labeling to include details on the new indication and required diagnostic methods, along with planning for the confirmatory studies mandated by the FDA.

Signal ManagementLabelingRegulatory Intelligence Lead
SOP Impact2 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicMHRA · UK · Updated Sep 4, 2026

Change to the definition of regulated activity with children from 1 September 2026

Urgency: High

Organizations must re-evaluate roles related to children's activities and prepare to request Enhanced DBS checks including access to the Children’s Barred List check starting from 1 September 2026.

Country ComplianceRegulatory Intelligence Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicUK Health Security Agency · UK · Updated Sep 7, 2026

Low Flu Vaccination Rates Among Primary School Children

Urgency: High

Parents are reminded to complete and return flu vaccination consent forms promptly as vaccination sessions in schools are set to start this week, aiming for completion by late November.

Signal ManagementPV Quality Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: PV Quality Lead, Medical Safety Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicANSM (France) · France · Updated Sep 7, 2026Translated From French

Recall of Gore Viabahn Endoprosthesis with Bioactive Heparin Coating

Urgency: High

Health establishments receiving affected devices must be notified, and protocols established to ensure compliance with the recall.

Signal ManagementQPPV
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: QPPV, Medical Safety Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward